ScoreWhy is Zymeworks, Inc. ?
1
Poor Management Efficiency with a low ROE of 7.29%
- The company has been able to generate a Return on Equity (avg) of 7.29% signifying low profitability per unit of shareholders funds
2
With a growth in Operating Profit of 151.7%, the company declared Very Positive results in Sep 25
- The company has declared positive results for the last 2 consecutive quarters
- NET SALES(HY) At USD 76.34 MM has Grown at 116.61%
- NET PROFIT(HY) Higher at USD -17.29 MM
- RAW MATERIAL COST(Y) Fallen by -8.84% (YoY)
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 88.98%, its profits have risen by 34.2%
4
Rising Promoter Confidence
- Promoters have increased their stake in the company by 2.12% over the previous quarter and currently hold 4.08% of the company
- Promoters increasing their stake is a sign of high confidence in the future of the business
5
Market Beating Performance
- The stock has generated a return of 88.98% in the last 1 year, much higher than market (S&P 500) returns of 14.90%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Zymeworks, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
39.84%
EBIT Growth (5y)
10.99%
EBIT to Interest (avg)
-104.04
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.81
Sales to Capital Employed (avg)
0.40
Tax Ratio
6.07%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
25.85%
ROE (avg)
7.29%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.48
EV to EBIT
-21.33
EV to EBITDA
-26.05
EV to Capital Employed
21.06
EV to Sales
11.20
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-98.72%
ROE (Latest)
-19.82%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
NET SALES(HY)
At USD 76.34 MM has Grown at 116.61%
NET PROFIT(HY)
Higher at USD -17.29 MM
RAW MATERIAL COST(Y)
Fallen by -8.84% (YoY
-4What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -62.55 MM
NET SALES(Q)
At USD 27.61 MM has Fallen at -10.1%
Here's what is working for Zymeworks, Inc.
Net Profit
Higher at USD -17.29 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Profit
At USD -17.29 MM has Grown at 65.6%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Raw Material Cost
Fallen by -8.84% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Zymeworks, Inc.
Operating Cash Flow
Lowest at USD -62.55 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Net Sales
At USD 27.61 MM has Fallen at -10.1%
over average net sales of the previous four periods of USD 30.72 MMMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
